Apellis Pharmaceuticals, Inc. (APLS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1233453,
    "name": "Apellis Pharmaceuticals, Inc.",
    "stock_name": "Apellis Pharmaceuticals, Inc.",
    "full_name": "Apellis Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/apellis-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "22.19",
    "chg": 1.53,
    "chgp": "7.41%",
    "dir": 1,
    "prev_price": "20.66",
    "mcapval": "3,398.46",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US03753U1060",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "5.12 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/apellis-pharmaceuticals-inc-1233453-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Apellis Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-apellis-pharmaceuticals-inc-technically-bullish-or-bearish-3673571",
        "imagepath": "",
        "date": "2025-11-05 11:19:55",
        "description": "As of 31 October 2025, the technical trend for Apellis Pharmaceuticals, Inc. has changed from bullish to sideways. The current technical stance is neutral, with mixed signals across various indicators. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish. The weekly RSI shows no signal, but the monthly RSI is bearish. Bollinger Bands indicate bearish conditions for both weekly and monthly periods. Daily moving averages are mildly bullish, but the KST and Dow Theory show no trend on both weekly and monthly time frames. \n\nIn terms of performance, the stock has underperformed significantly against the S&P 500 across multiple periods, with a year-to-date return of -35.85% compared to the S&P 500's 16.30%, and a one-year return of -26.84% against 19.89% for the benchmark...."
      },
      {
        "title": "Is Apellis Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-apellis-pharmaceuticals-inc-technically-bullish-or-bearish-3670759",
        "imagepath": "",
        "date": "2025-11-04 11:31:22",
        "description": "As of 31 October 2025, the technical trend for Apellis Pharmaceuticals, Inc. has changed from bullish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a bearish trend for both weekly and monthly periods. Daily moving averages show a mildly bullish signal. Overall, there is no clear trend according to Dow Theory and the On-Balance Volume (OBV) shows no trend as well. \n\nIn terms of performance, Apellis has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -35.16% compared to the S&P 500's 16.30%, and a one-year return of -26.05% versus 19.89% for the index...."
      },
      {
        "title": "Is Apellis Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-apellis-pharmaceuticals-inc-technically-bullish-or-bearish-3666352",
        "imagepath": "",
        "date": "2025-11-03 11:30:25",
        "description": "As of 31 October 2025, the technical trend for Apellis Pharmaceuticals, Inc. has changed from bullish to sideways. The current technical stance is neutral, with mixed indicators influencing the outlook. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish. Bollinger Bands and KST are bearish on both weekly and monthly timeframes. Daily moving averages show a mildly bullish signal. There is no trend indicated by Dow Theory or OBV on either timeframe. \n\nIn terms of performance, the stock has underperformed the S&P 500 across all multi-period returns, with a year-to-date decline of 32.72% compared to the S&P 500's gain of 16.30%...."
      },
      {
        "title": "Is Apellis Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-apellis-pharmaceuticals-inc-technically-bullish-or-bearish-3664468",
        "imagepath": "",
        "date": "2025-11-02 11:16:22",
        "description": "As of 31 October 2025, the technical trend for Apellis Pharmaceuticals, Inc. has changed from bullish to sideways. The current technical stance is neutral, with a mildly bearish outlook on the weekly MACD and KST, while the monthly MACD shows a mildly bullish signal. However, both the weekly and monthly Bollinger Bands indicate a bearish trend. Daily moving averages are mildly bullish, but overall, the indicators suggest a lack of strong momentum in either direction. \n\nIn terms of performance, the stock has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -32.72% compared to the S&P 500's 16.30%, and a one-year return of -21.24% against the S&P 500's 19.89%...."
      },
      {
        "title": "Apellis Pharmaceuticals Hits Day Low of $20.66 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/apellis-pharmaceuticals-hits-day-low-of-2066-amid-price-pressure-3662106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ApellisPharmace_priceRelatedfactors_3662106.png",
        "date": "2025-10-31 16:57:17",
        "description": "Apellis Pharmaceuticals, Inc. has faced significant stock volatility, hitting an intraday low and experiencing notable declines over various time frames. The company reports a substantial net loss and high leverage, with ongoing financial pressures reflected in its negative return on equity. Its performance continues to attract scrutiny within the industry."
      },
      {
        "title": "Apellis Pharmaceuticals Faces Weak Start with 17.3% Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/apellis-pharmaceuticals-faces-weak-start-with-173-gap-down-amid-market-concerns-3712428",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ApellisPharmace_gapdown_3712428.png",
        "date": "2025-10-31 16:40:13",
        "description": "Apellis Pharmaceuticals, Inc. experienced a notable decline in its stock performance, contrasting with the stable S&P 500. The company, with a market capitalization of approximately USD 3.4 billion, faces financial challenges, including a negative return on equity and no dividend yield, amid mixed technical indicators."
      },
      {
        "title": "Apellis Pharmaceuticals Stock Hits Day High with 8.94% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/apellis-pharmaceuticals-stock-hits-day-high-with-894-surge-3626716",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ApellisPharmace_priceRelatedfactors_3626716.png",
        "date": "2025-10-16 18:57:12",
        "description": "Apellis Pharmaceuticals, Inc. saw a notable increase in its stock today, contrasting with a slight decline in the S&P 500. While the company has shown modest gains over the past week and month, it faces significant challenges, including a year-to-date decline and ongoing financial pressures."
      },
      {
        "title": "Apellis Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/apellis-pharmaceuticals-forms-golden-cross-signaling-potential-bullish-breakout-3559470",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ApellisPharmace_goldencross_3559470.png",
        "date": "2025-09-23 15:43:47",
        "description": "Apellis Pharmaceuticals has recently achieved a Golden Cross, indicating a potential shift in momentum. Current technical indicators present a mixed outlook, with varying bullish and bearish signals. Despite a year-long performance decline, the stock has shown short-term gains, prompting interest in its future trading dynamics."
      },
      {
        "title": "Is Apellis Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-apellis-pharmaceuticals-inc-technically-bullish-or-bearish-3545951",
        "imagepath": "",
        "date": "2025-09-20 19:21:59",
        "description": "As of 7 July 2025, the technical trend for Apellis Pharmaceuticals, Inc. has changed from bearish to mildly bearish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating some positive momentum. However, the daily moving averages are bearish, suggesting short-term weakness. The Bollinger Bands show a mildly bullish stance on the weekly chart but bearish on the monthly. Dow Theory reflects a mildly bearish trend on the weekly and mildly bullish on the monthly, while the KST is bullish weekly but bearish monthly. The OBV is mildly bearish weekly and mildly bullish monthly.\n\nIn terms of performance, Apellis has significantly underperformed the S&P 500 across all multi-period returns, with a year-to-date return of -26.73% compared to the S&P 500's 12.22%, and a one-year return of -34.38% versus 17.14%. Overall, the technical stance is mildly bearish, with mixed signals across differen..."
      }
    ],
    "total": 16,
    "sid": "1233453",
    "stock_news_url": "https://www.marketsmojo.com/news/apellis-pharmaceuticals-inc-1233453"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Apellis Pharmaceuticals, Inc. technically bullish or bearish?

2025-11-05 11:19:55

As of 31 October 2025, the technical trend for Apellis Pharmaceuticals, Inc. has changed from bullish to sideways. The current technical stance is neutral, with mixed signals across various indicators. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish. The weekly RSI shows no signal, but the monthly RSI is bearish. Bollinger Bands indicate bearish conditions for both weekly and monthly periods. Daily moving averages are mildly bullish, but the KST and Dow Theory show no trend on both weekly and monthly time frames. In terms of performance, the stock has underperformed significantly against the S&P 500 across multiple periods, with a year-to-date return of -35.85% compared to the S&P 500's 16.30%, and a one-year return of -26.84% against 19.89% for the benchmark....

Is Apellis Pharmaceuticals, Inc. technically bullish or bearish?

2025-11-04 11:31:22

As of 31 October 2025, the technical trend for Apellis Pharmaceuticals, Inc. has changed from bullish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish. Bollinger Bands indicate a bearish trend for both weekly and monthly periods. Daily moving averages show a mildly bullish signal. Overall, there is no clear trend according to Dow Theory and the On-Balance Volume (OBV) shows no trend as well. In terms of performance, Apellis has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -35.16% compared to the S&P 500's 16.30%, and a one-year return of -26.05% versus 19.89% for the index....

Is Apellis Pharmaceuticals, Inc. technically bullish or bearish?

2025-11-03 11:30:25

As of 31 October 2025, the technical trend for Apellis Pharmaceuticals, Inc. has changed from bullish to sideways. The current technical stance is neutral, with mixed indicators influencing the outlook. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish. Bollinger Bands and KST are bearish on both weekly and monthly timeframes. Daily moving averages show a mildly bullish signal. There is no trend indicated by Dow Theory or OBV on either timeframe. In terms of performance, the stock has underperformed the S&P 500 across all multi-period returns, with a year-to-date decline of 32.72% compared to the S&P 500's gain of 16.30%....

Is Apellis Pharmaceuticals, Inc. technically bullish or bearish?

2025-11-02 11:16:22

As of 31 October 2025, the technical trend for Apellis Pharmaceuticals, Inc. has changed from bullish to sideways. The current technical stance is neutral, with a mildly bearish outlook on the weekly MACD and KST, while the monthly MACD shows a mildly bullish signal. However, both the weekly and monthly Bollinger Bands indicate a bearish trend. Daily moving averages are mildly bullish, but overall, the indicators suggest a lack of strong momentum in either direction. In terms of performance, the stock has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -32.72% compared to the S&P 500's 16.30%, and a one-year return of -21.24% against the S&P 500's 19.89%....

Apellis Pharmaceuticals Hits Day Low of $20.66 Amid Price Pressure

2025-10-31 16:57:17

Apellis Pharmaceuticals, Inc. has faced significant stock volatility, hitting an intraday low and experiencing notable declines over various time frames. The company reports a substantial net loss and high leverage, with ongoing financial pressures reflected in its negative return on equity. Its performance continues to attract scrutiny within the industry.

Apellis Pharmaceuticals Faces Weak Start with 17.3% Gap Down Amid Market Concerns

2025-10-31 16:40:13

Apellis Pharmaceuticals, Inc. experienced a notable decline in its stock performance, contrasting with the stable S&P 500. The company, with a market capitalization of approximately USD 3.4 billion, faces financial challenges, including a negative return on equity and no dividend yield, amid mixed technical indicators.

Apellis Pharmaceuticals Stock Hits Day High with 8.94% Surge

2025-10-16 18:57:12

Apellis Pharmaceuticals, Inc. saw a notable increase in its stock today, contrasting with a slight decline in the S&P 500. While the company has shown modest gains over the past week and month, it faces significant challenges, including a year-to-date decline and ongoing financial pressures.

Apellis Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout

2025-09-23 15:43:47

Apellis Pharmaceuticals has recently achieved a Golden Cross, indicating a potential shift in momentum. Current technical indicators present a mixed outlook, with varying bullish and bearish signals. Despite a year-long performance decline, the stock has shown short-term gains, prompting interest in its future trading dynamics.

Is Apellis Pharmaceuticals, Inc. technically bullish or bearish?

2025-09-20 19:21:59

As of 7 July 2025, the technical trend for Apellis Pharmaceuticals, Inc. has changed from bearish to mildly bearish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating some positive momentum. However, the daily moving averages are bearish, suggesting short-term weakness. The Bollinger Bands show a mildly bullish stance on the weekly chart but bearish on the monthly. Dow Theory reflects a mildly bearish trend on the weekly and mildly bullish on the monthly, while the KST is bullish weekly but bearish monthly. The OBV is mildly bearish weekly and mildly bullish monthly. In terms of performance, Apellis has significantly underperformed the S&P 500 across all multi-period returns, with a year-to-date return of -26.73% compared to the S&P 500's 12.22%, and a one-year return of -34.38% versus 17.14%. Overall, the technical stance is mildly bearish, with mixed signals across differen...

View All News